Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published
MOTS-c targets mitochondrial function and metabolic efficiency, working through different pathways than AOD-9604
Berney M, Berney-Meyer L, Wong KW, Chen B, Chen M, Kim J, Wang J, Harris D, Parkhill J, Chan J, Wang F
The body can absorb between 55% and 97% of B12 from injections, compared to only about 1.3% from a high-dose oral supplement
Rapid Absorption : The nasal mucosa is highly vascularized, allowing for quick absorption of the peptides into the bloodstream, leading to faster onset of action
BPC-157 accelerates tissue repair while TB-500 reduces inflammation and enhances cellular migration, creating optimal conditions for healing
US$ 26.95
US$ 26.66
US$ 26.76
US$ 22.73
US$ 24.60
US$ 22.84
US$ 22.55
